NIAID | Technology Transfer

CD47-targeted Therapies For The Treatment Of Infectious Disease

Read more about CD47-targeted Therapies For The Treatment Of Infectious Disease

Czech Republic
22185801.2
Filed on 2022-07-19

CD47-targeted Therapies For The Treatment Of Infectious Disease

Read more about CD47-targeted Therapies For The Treatment Of Infectious Disease

Slovakia
22185801.2
Filed on 2022-07-19

CD47-targeted Therapies For The Treatment Of Infectious Disease

Read more about CD47-targeted Therapies For The Treatment Of Infectious Disease

Switzerland
22185801.2
Filed on 2022-07-19

CD47-targeted Therapies For The Treatment Of Infectious Disease

Read more about CD47-targeted Therapies For The Treatment Of Infectious Disease

Greece
22185801.2
Filed on 2022-07-19

CD47-targeted Therapies For The Treatment Of Infectious Disease

Read more about CD47-targeted Therapies For The Treatment Of Infectious Disease

Ireland
22185801.2
Filed on 2022-07-19

CD47-targeted Therapies For The Treatment Of Infectious Disease

Read more about CD47-targeted Therapies For The Treatment Of Infectious Disease

United Kingdom
22185801.2
Filed on 2022-07-19

CD47-targeted Therapies For The Treatment Of Infectious Disease

Read more about CD47-targeted Therapies For The Treatment Of Infectious Disease

Poland
22185801.2
Filed on 2022-07-19

CD47-targeted Therapies For The Treatment Of Infectious Disease

Read more about CD47-targeted Therapies For The Treatment Of Infectious Disease

Turkey
22185801.2
Filed on 2022-07-19

CD47-targeted Therapies For The Treatment Of Infectious Disease

Read more about CD47-targeted Therapies For The Treatment Of Infectious Disease

Spain
22185801.2
Filed on 2022-07-19

VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES

Read more about VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES

Japan
2024-178707
Filed on 2024-10-11

Subscribe to NIAID